` Comparison: 600535, ROG - Alpha Spread

600535
vs
ROG

Over the past 12 months, Tasly Pharmaceutical Group Co Ltd has underperformed ROG, delivering a return of +12% compared to the ROG's +29% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
600535
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
20.16 CNY
Undervaluation 24%
Intrinsic Value
Price
ROG Intrinsic Value
452.26 CHF
Undervaluation 25%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Tasly Pharmaceutical Group Co Ltd
SSE:600535
15.31 CNY
Roche Holding AG
SIX:ROG
340.8 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
600535, ROG

600535
ROG
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Tasly Pharmaceutical Group Co Ltd
Revenue
Roche Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
600535, ROG

600535
ROG
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Roche Holding AG
SIX:ROG
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Tasly Pharmaceutical Group Co Ltd
65.7%
ROG
73.9%

Operating Margin

Tasly Pharmaceutical Group Co Ltd
13.6%
ROG
33.8%

Net Margin

Tasly Pharmaceutical Group Co Ltd
13.2%
ROG
15.3%

FCF Margin

Tasly Pharmaceutical Group Co Ltd
14.8%
ROG
21.4%

ROE

Tasly Pharmaceutical Group Co Ltd
8.8%
ROG
32.7%

ROA

Tasly Pharmaceutical Group Co Ltd
6.9%
ROG
9.9%

ROIC

Tasly Pharmaceutical Group Co Ltd
7.5%
ROG
19.4%

ROCE

Tasly Pharmaceutical Group Co Ltd
8.6%
ROG
30.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
600535, ROG

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600535, ROG

Loading
600535
ROG
Difference
www.alphaspread.com

Performance By Year
600535, ROG

Loading
600535
ROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 600535 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account